Dr. Mallik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6201 Harry Hines Blvd
Dallas, TX 75235Phone+1 214-633-5555Fax+1 972-669-7190
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2007 - 2010
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2004 - 2007
- University of Texas Southwestern Medical SchoolClass of 2004
Certifications & Licensure
- VA State Medical License 2022 - 2026
- MO State Medical License 2022 - 2025
- NM State Medical License 2022 - 2025
- TX State Medical License 2007 - 2025
- OH State Medical License 2022 - 2024
- NY State Medical License 2007 - 2011
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
Publications & Presentations
PubMed
- Author Correction: A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas.Leandro C Cerchietti, Eloisi C Lopes, Shao Ning Yang, Katerina Hatzi, Karen L Bunting
Nature Medicine. 2024-05-01 - 7 citationsNivolumab-induced vitiligo in a metastatic melanoma patient: A case report.Lindsay Edmondson, Leticia V Smith, Alka Mallik
Journal of Oncology Pharmacy Practice. 2017-12-01 - Peri- and postoperative haematologic management in a patient with type 2 von Willebrand disease undergoing mitral valve replacementJ. E. Arnason, Alka Mallik, M. De Sancho
Haemophilia. 2011-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: